Pancreatic cancer
SkyFoundation
Funding science. Supporting patients.
Patient Resources
Article 04 of 065 min read

Clinical trials access

Clinical trials are research studies that test new treatments, combinations or approaches. They play a critical role in advancing care and can give patients access to therapies not yet available outside the research setting.

Clinical trials access

Why clinical trials matter

Expanded options. Trials may include targeted therapies, immunotherapies or novel drug combinations.
Improved outcomes. Research shows patients treated at centers offering clinical trials often live longer — even if they do not participate in a trial themselves.
Advancing science. Participation helps researchers understand pancreatic cancer better, improving treatment for future patients.

Types of trial

Phase I. Tests safety, dosage and side effects of a new treatment.
Phase II. Evaluates how well a treatment works for a specific cancer type.
Phase III. Compares the new treatment against the current standard of care.
Precision medicine trials. Match treatment to genetic or molecular features of the tumor, such as BRCA mutations or MSI-H status.

How to find a trial

Sky Foundation recommends TriCan Health, which lets you filter by location (state or hospital system), stage of cancer, type of intervention — drug, surgery or device — and enrollment status.

Source
Browse trials on TriCan Health
Source
ClinicalTrials.gov — Pancreatic cancer studies

Michigan options

Karmanos Cancer Institute has been an NCI-Designated Comprehensive Cancer Center since 1978 — one of only 57 in the United States, and the only cancer hospital in Michigan with the designation. That designation reflects scientific excellence and expertise across clinical, laboratory, behavioral and population-based research.

Karmanos offers treatments and trials not available at other hospitals in the state, and welcomes patients coming in for a second-opinion consultation.

Source
Clinical trials at Karmanos Cancer Institute

When to consider a trial

At initial diagnosis, particularly for borderline resectable or advanced disease.
Before starting chemotherapy, to explore whether first-line trial options are available.
After progression on standard treatment, when new approaches may be available.

Support from Sky Foundation

We partner with leading institutions, including Henry Ford Health, to connect patients directly with appropriate trials. We also maintain relationships with national research networks, helping patients identify opportunities quickly.

Key takeaway

Clinical trials may offer access to new treatments that could improve outcomes. Ask your oncologist about trial eligibility as early as possible.

Next article
Resources for patients and caregivers
SkyFoundation
PO Box 1780 · Birmingham, MI 48012
(248) 385-5143
© 2026 SKY FOUNDATION, INC · 501(c)(3) · EIN 26-2720583
PRIVACY POLICY
GIVE NOW